This study was supported by NeuralStem, Inc., and Johns Hopkins Project RESTORE.

ملاحظة: تمت الموافقة على جميع الإجراءات الحيوانية من لجنة رعاية الحيوان واستخدام جونز هوبكنز. آلات التخدير تتطلب التفتيش السنوي والمعايرة حسب الضرورة. 1. التخدير وتحديد المواقع <ol style=";text-align:right;direction:rtl"><li style=";text-align:right;direction:rtl"> التخدير. <ol style=";text-align:right;direction:rtl"><li style=";text-align:right;direction:rtl"> أداء جميع العمليات الجراحية تحت التخدير مع 2-3٪ isofluorane. تأكيد مستوى مناسب من التخدير من قرصة أخمص قدميها، ومعدل التنفس. تأكد من أن الفئران لا تتوانى في استجابة لقرصة أخمص قدميه. ملاحظة: تتوانى يشير التخدير أن يفوت الأوان، وقد يتطلب تخدير أطول قبل بداية أو تركيز isofluorane العالي. معدل التنفس أقل من 1 التنفس كل 2 ثانية بطيئة جدا مما يدل على التخدير مرتفع جدا، وقد تتطلب البرق للتركيز isofluorane. </li><li style=";text-align:right;direction:rtl"> تأمين الحيوان عند الضرورة لتجنب حركة الرأس أثناء العملية. وضع قطرة من يدوكائين على العين الجراحية. استخدام الدموع الاصطناعية كل 10 دقيقة لمنع جفاف بينما تحت التخدير. منححقن البوبرينورفين 0.01 مغ / كغ SC ما قبل الجراحة وبعد ذلك كل 6-8 ساعة حسب الحاجة. </li></ol></li><li style=";text-align:right;direction:rtl"> تحديد المواقع. <ol style=";text-align:right;direction:rtl"><li style=";text-align:right;direction:rtl"> وضع الفئران في إطار التجسيمي والدفء مع وسادة التدفئة. الرطب الفراء فروة الرأس مع الكحول مع الحرص على تجنب التعرض على العينين. استخدام أدوات معقمة وتقنية معقمة للحد من خطر العدوى بعد العمليات الجراحية. </li></ol></li></ol> 2. التحكم في العين <ol style=";text-align:right;direction:rtl"><li style=";text-align:right;direction:rtl"> وضع خياطة 4-0 في الملتحمة الجانبية وربط ذلك مع ما يكفي من خياطة للسماح الجر لطيف. </li></ol> 3. تشريح <ol style=";text-align:right;direction:rtl"><li style=";text-align:right;direction:rtl"> تشريح الأولي. <ol style=";text-align:right;direction:rtl"><li style=";text-align:right;direction:rtl"> جعل بوصة شق ~ 1 في الجلد المغطي التلال المداري باستخدام حجم 10 مشرط كما هو مبين في الشكل 1. يتراجع عن الجلد واللفافة الكامنة وتشريح بعناية بعيدا اللفافة. لمنع النزيف في العمليات الجراحية، وتجنب قطع الأوعية الدموية في حين تشريح اللفافة. استخدام استراتيجيا ررنصائح القطن ماجد لتوفير الارقاء. </li></ol></li><li style=";text-align:right;direction:rtl"> تشريح أعمق. ملاحظة: مع الجر لطيف على الملتحمة سحب العين السقوط والخروج من مأخذ، وسوف يأتي عضلة المدارية متفوقة في طريقة العرض. من أجل فضح العصب البصري، يجب أن تقطع هذه العضلات وإزالة الدهون الرجعية المدارية. الدهون يمكن التخلص منها ويجب أن لا يتم استبدال بعد الحقن. من هذه النقطة، يجب أن يكون لفافة العصب البصري المرئي وكأنه مجموعة من العصب البصري في حد ذاته، جنبا إلى جنب مع الأوعية الدموية ملفوفة في الجافية (الشكل 1). <ol style=";text-align:right;direction:rtl"><li style=";text-align:right;direction:rtl"> إجراء شق صغير في الجافية باستخدام مشرط أو 31 مقياس مشطوف إبرة لجعل ثقب أقل من صدمة. </li></ol></li></ol> 4. ماصة الحاقن <ol style=";text-align:right;direction:rtl"><li style=";text-align:right;direction:rtl"> سحب micropipette الزجاج ليبلغ قطرها 50-100 ميكرون. لتوفير الاستقرار وتركيب micropipette على micromanipulator ونعلق على حقنة هاميلتون متصلة مضخة التسريب. </li><li style=";text-align:right;direction:rtl"> سحب ما يصل حبات (أو الخلايا الجذعية)أعيد في حجم 0،5-1،0 ميكرولتر في micropipette الوراء جنبا إلى جنب مع 0.5 حجم ميكرولتر من حل الميثيل الأزرق قبل وبعد. ملاحظة: ان معدل ضخ المقرر أن 0،5-2 ميكرولتر لكل دقيقة يمنع الصدمات في العصب البصري. </li></ol> 5. حقن <ol style=";text-align:right;direction:rtl"><li style=";text-align:right;direction:rtl"> خفض غيض من micropipette على العصب البصري فقط فوق الجافية رصدت. ملاحظة: حركة صغيرة، ولكن انتعش من طرف زجاج في نتائج العصب البصري في أقل الأضرار. كما تبدأ مضخة التسريب، ينبغي للالميثيل صبغة زرقاء تسليط الضوء على منطقة العصب البصري حقن. ينبغي أن تظل الصبغة المحلية داخل العصب البصري دون تسرب في الفضاء تحت العنكبوتية. </li><li style=";text-align:right;direction:rtl"> اتبع الفرقة الثانية للأزرق الميثيل للوقوف عند حقن الخلايا الجذعية اكتمال وتشغيل مضخة التسريب قبالة كما يتم حقن الجرعة الثانية من اللون الأزرق الميثيل. الحفاظ على micropipette لا يزال داخل العصب البصري لمدة 2 دقيقة لكل وحدة تخزين 1 ميكرولتر حقنها لمنع ارتفاعضغط طرد على الانسحاب من micropipette. ملاحظة: هذا أسلوب بديل لتوصيل طرف ماصة لشغل حقنة الهواء التي يمكن التلاعب بها يدويا. وفي كلتا الحالتين، وتجنب استخدام القوة المفرطة للحد من الأضرار التي لحقت الأعصاب البصرية. ونحن نوصي حقن لا يزيد عن 2 ميكرولتر من حجم في كل العصب البصري. </li></ol> 6. متابعة <ol style=";text-align:right;direction:rtl"><li style=";text-align:right;direction:rtl"> فوري. <ol style=";text-align:right;direction:rtl"><li style=";text-align:right;direction:rtl"> عندما حقن اكتمال، وإزالة micropipette جنبا إلى جنب مع أي نصائح القطن المستخدمة لتوفير الارقاء. خياطة الجلد مع 3-0 الحرير وإزالة خياطة الملتحمة. </li><li style=";text-align:right;direction:rtl"> الحفاظ على الفئران دافئة على وسادة التدفئة حتى خروجها من التخدير. لا تترك حيوان غير المراقب حتى استعاد وعيه أنه كاف للحفاظ على الاستلقاء القصية. لا يعودون الحيوان الذي خضع لعملية جراحية للشركة من الحيوانات الأخرى حتى تعافى تماما. </li><li style=";text-align:right;direction:rtl"> إذا كان الحيوان هو اظهار علامات الألم بما في ذلك الخمول المفرط، وترنح، أو يتنفس جاهدز، إدارة التسكين المناسب مع البوبرينورفين العضلي (0.05 ملغ / كلغ) ما يصل إلى ثلاث مرات يوميا. </li></ol></li><li style=";text-align:right;direction:rtl"> طويل الأمد. <ol style=";text-align:right;direction:rtl"><li style=";text-align:right;direction:rtl"> لساعة 24-48 المقبلة، ومراقبة الفئران لمضاعفات الجراحة بما في ذلك تورم أو إفرازات من الجرح أو غيرها من علامات الألم مثل اللفظ، والمظهر منحنية، وعدم النظافة الشخصية، أو لا يأكل. النظر في التشاور مع طبيب بيطري أو القتل الرحيم الأخلاقي عند الضرورة. </li></ol></li></ol>

<ol>
	<li>Dahlmann-Noor, A., Vijay, S., Jayaram, H., Limb, A., Khaw, P. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Current+approaches+and+future+prospects+for+stem+cell+rescue+and+regeneration+of+the+retina+and+optic+nerve.">Current approaches and future prospects for stem cell rescue and regeneration of the retina and optic nerve.</a> Canadian journal of ophthalmology Journal canadien d'ophtalmologie. 45 (4), 333-341 (2010).</li><li>Quigley, H. A., Iglesia, D. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Stem+cells+to+replace+the+optic+nerve.">Stem cells to replace the optic nerve.</a> Eye. 18 (11), 1085-1088 (2004).</li><li>Ghaffarieh, A., Levin, L. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optic+nerve+disease+and+axon+pathophysiology.">Optic nerve disease and axon pathophysiology.</a> International review of neurobiology. 105, 1-17 (2012).</li><li>Fukui, Y., Hayasaka, S., Bedi, K. S., Ozaki, H. S., Takeuchi, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Quantitative+study+of+the+development+of+the+optic+nerve+in+rats+reared+in+the+dark+during+early+postnatal+life.">Quantitative study of the development of the optic nerve in rats reared in the dark during early postnatal life.</a> Journal of anatomy. 174, 37-47 (1991).</li><li>Celestre, P. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Minimally+invasive+approaches+to+the+cervical+spine.">Minimally invasive approaches to the cervical spine.</a> The Orthopedic clinics of North America. 43 (1), 137-147 (2012).</li><li>Hallas, B. H., Wells, M. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+Novel+Technique+for+Multiple+Injections+into+the+Mammalian+Optic+Nerve.">A Novel Technique for Multiple Injections into the Mammalian Optic Nerve.</a> Kopf Carrier. 54, (2001).</li><li>Harvey, A. R., Hellstrom, M., Rodger, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Gene+therapy+and+transplantation+in+the+retinofugal+pathway.">Gene therapy and transplantation in the retinofugal pathway.</a> Progress in brain research. 175, 151-161 (2009).</li><li>Adachi-Usami, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optic+neuritis--from+diagnosis+to+optic+nerve+transplantation.">Optic neuritis--from diagnosis to optic nerve transplantation.</a> Nippon Ganka Gakkai zasshi. 104 (12), 841-857 (2000).</li><li>Slater, B. J., Vilson, F. L., Guo, Y., Weinreich, D., Hwang, S., Bernstein, S. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optic+nerve+inflammation+and+demyelination+in+a+rodent+model+of+nonarteritic+anterior+ischemic+optic+neuropathy.">Optic nerve inflammation and demyelination in a rodent model of nonarteritic anterior ischemic optic neuropathy.</a> Investigative ophthalmology &amp; visual science. 54 (13), 7952-7961 (2013).</li><li>Zarbin, M. A., Arlow, T., Ritch, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Regenerative+nanomedicine+for+vision+restoration.">Regenerative nanomedicine for vision restoration.</a> Mayo Clinic proceedings. 88 (12), 1480-1490 (2013).</li></ol>

The authors have no meaningful disclosures to report.

Direct injection into the optic nerve of stem cells or other products intended to facilitate regeneration provides a convenient model compared to other means of injections into the CNS. This technique takes less time, requires less total anesthesia, avoids drilling or removing skull or bone tissue, reduces complications rates and allows for more rapid recovery following surgery. 
The most critical steps in this protocol include: 1. Adequate hemostasis in the surgical field to allow clear visua...

يوفر العصب البصري موقعا مثاليا للنظام العصبي المركزي (CNS) البحوث التجدد بما في ذلك شروط العيون مثل التهاب العصب البصري، والزرق والصدمات النفسية. حقن مجموعة متنوعة من الخلايا الجذعية أثبتت إما فعالية أو أظهرت الوعد في استبدال المايلين المفقود، وزيادة عدد المحاور و / أو الوقاية من الأمراض التنكسية. 1،2 العصب البصري البشري يحتوي على ما يقرب من 1.2 مليون محاور متوازية متجهة من الشبكية إلى تصالبة التي يبلغ قطرها حوالي 3.0-3.5 مم. 3 لنموذج الأمراض التي تصيب الإنسان في المختبر، وقد تم استخدام الفئران في كثير من الأحيان. والعصب البصري الفئران الكبار يحتوي على حوالي 100،000 المحاور داخل يبلغ قطرها حوالي 0.5 مم. 4 واحدة من القيود الرئيسية في الجهاز العصبي المركزي البحوث التجديدي هو الوصول العظم المباشر. المضاعفات والمخاطر الجراحية للحيوان أعلى عندما تتم إزالة الجمجمة أو الفقرات. وعلى غرار فوائدالنهج الحد الأدنى الغازية في العمود الفقري، 5 المباشر حقن العصب البصري دون فتح الجمجمة عرض تخفيض المضاعفات وانتعاش أكثر سرعة. وقد استخدمت هذه التقنية في الدراسات السابقة. 6 وفي هذه المخطوطة والفيديو المصاحبة لها، علينا أن نظهر إجراء المناظير لحقن الخلايا الجذعية في العصب البصري الفئران.

<table><tbody><tr><td>Lewis rat</td><td>Charles River</td><td>4</td><td>Any rat strain will work.</td></tr><tr><td>Anesthesia machine</td><td>Surgivet</td><td>CDS9000</td><td>CDS 9000 Small Animal Anesthesia Machine - Pole Mount</td></tr><tr><td>Infusion pump</td><td>Stoelting</td><td>53129</td><td></td></tr><tr><td>Dissection microscope</td><td>National Optical</td><td>409-411-1105</td><td></td></tr><tr><td>Fiber-optic light source</td><td>Fisher Scientific</td><td>12-562-21</td><td></td></tr><tr><td>Dissection and Stereotaxic Instrument</td><td>Stoelting</td><td>51400</td><td></td></tr><tr><td>Pipette Puller</td><td>Kopf</td><td>750</td><td></td></tr><tr><td>Pipettes</td><td>World Precision Instruments</td><td>18150-6</td><td></td></tr><tr><td>Disposable scalpel blades</td><td>Harvard Apparatus</td><td>810-15-021</td><td></td></tr><tr><td>Iridectomy scissors</td><td>Electron Microscopy Sciences</td><td>Uniband LA-4XF</td><td></td></tr></tbody></table>

minimally-invasive technique for injection into rat optic nerve

The rat optic nerve is a useful model for stem cell regeneration research. Direct injection into the rat optic nerve allows delivery into the central nervous system in a minimally-invasive surgery without bone removal. This technique describes an approach to visualization and direct injection of the optic nerve following minor fascial dissection from the orbital ridge, using a conjunctival traction suture to gently pull the eye down and out. Representative examples of an injected optic nerve show successful injection of dyed beads.

في ختام التجربة، تم التضحية الفئران ومع perfused 4٪ لامتصاص العرق. تم الأعصاب البصرية تشريح بعناية والتي شنت لناظم البرد باجتزاء الشكل 2 يوضح مثال على الفئران العصب البصري كله في الطاقة المنخفضة التي تم حقن صبغة زرقاء ايفانز من أجل رؤية الموقع. السهم يحدد الموقع ...

Watch this Scientific Journal Video about Minimally-invasive Technique for Injection into Rat Optic Nerve at JoVE.com

Minimally-invasive Technique for Injection into Rat Optic Nerve

Direct injection into the rat optic nerve is useful for regenerative research. We demonstrate a minimally-invasive technique for direct injection into a rat optic nerve that does not involve opening the skull. Using this method, surgical complications are minimized and recovery is more rapid.

تقنيات الحد الأدنى الغازية لحقن الفئران في العصب البصري

The rat optic nerve is a useful model for stem cell regeneration research. Direct injection into the rat optic nerve allows delivery into the central ...

minimally-invasive-technique-for-injection-into-rat-optic-nerve

Research

JoVE Journal

Neuroscience

9.6K Views.  Johns Hopkins University. Direct injection into the rat optic nerve is useful for regenerative research. We demonstrate a minimally-invasive technique for direct injection into a rat optic nerve that does not involve opening the skull. Using this method, surgical complications are minimized and recovery is more rapid. 

Video: Minimally-invasive Technique for Injection into Rat Optic Nerve

Methods for Experimental Manipulations after Optic Nerve Transection in the Mammalian CNS

Retinal ganglion cells (RGCs) are CNS neurons that output visual information from the retina to the brain, via the optic nerve. The optic nerve can be accessed within the orbit of the eye and completely transected (axotomized), cutting the axons of the entire RGC population. Optic nerve transection is a reproducible model of apoptotic neuronal cell death in the adult CNS 1-4. This model is particularly attractive because the vitreous chamber of the eye acts as a capsule for drug delivery to the retina, permitting experimental manipulations via intraocular injections. The diffusion of chemicals through the vitreous fluid ensures that they act upon the entire RGC population. Viral vectors, plasmids or short interfering RNAs (siRNAs) can also be delivered to the vitreous chamber in order to infect or transfect retinal cells 5-12. The high tropism of Adeno-Associated Virus (AAV) vectors is beneficial to target RGCs, with an infection rate approaching 90% of cells near the injection site 6, 7, 13-15. Moreover, RGCs can be selectively transfected by applying siRNAs, plasmids, or viral vectors to the cut end of the optic nerve 16-19 or injecting vectors into their target the superior colliculus 10. This allows researchers to study apoptotic mechanisms in the injured neuronal population without confounding effects on other bystander neurons or surrounding glia. RGC apoptosis has a characteristic time-course whereby cell death is delayed 3-4 days postaxotomy, after which the cells rapidly degenerate. This provides a window for experimental manipulations directed against pathways involved in apoptosis. Manipulations that directly target RGCs from the transected optic nerve stump are performed at the time of axotomy, immediately after cutting the nerve. In contrast, when substances are delivered via an intraocular route, they can be injected prior to surgery or within the first 3 days after surgery, preceding the initiation of apoptosis in axotomized RGCs. In the present article, we demonstrate several methods for experimental manipulations after optic nerve transection.

Optic Nerve transection is a widely used model of adult CNS injury. This model is ideal for performing a number of experimental manipulations that target the retina globally or directly target the injured neuronal population of retinal ganglion cells.

أساليب التلاعب التجريبية بعد Transection العصب البصري الثدييات في الجهاز العصبي المركزي

Retinal ganglion cells (RGCs) are CNS neurons that output visual information from the retina to the brain, via the optic nerve. The optic nerve can be ...

Intravitreous Injection for Establishing Ocular Diseases Model

Intravitreous injection is a widely used technique in visual sciences research. It can be used to establish animal models with ocular diseases or as direct application of local treatment. This video introduces how to use simple and inexpensive tools to finish the intravitreous injection procedure. Use of a 1 ml syringe, instead of a hemilton syringe, is used. Practical tips for how to make appropriate injection needles using glass pipettes with perfect tips, and how to easily connect the syringe needle with the glass pipette tightly together, are given.
To conduct a good intravitreous injection, there are three aspects to be observed: 1) injection site should not disrupt retina structure; 2) bleeding should be avoided to reduce the risk of infection; 3) lens should be untouched to avoid traumatic cataract. In brief, the most important point is to reduce the interruption of normal ocular structure. To avoid interruption of retina, the superior nasal region of rat eye was chosen. Also, the puncture point of the needle was at the par planar, which was about 1.5 mm from the limbal region of the rat eye. A small amount of vitreous is gently pushed out through the puncture hole to reduce the intraocular pressure before injection. With the 45&deg; injection angle, it is less likely to cause traumatic cataract in the rat eye, thus avoiding related complications and influence from lenticular factors. In this operation, there was no cutting of the conjunctiva and ocular muscle, no bleeding. With quick and minor injury, a successful intravitreous injection can be done in minutes. 
The injection set outlined in this particular protocol is specific for intravitreous injection. However, the methods and materials presented here can also be used for other injection procedures in drug delivery to the brain, spinal cord or other organs in small mammals.

Intravitreous injection is a widely used technique in visual sciences research for ocular diseases or as direct application of local treatment. This video demonstrated a protocol for intravitreous injection using a 1ml syringe with glass pipette. Useful tips about avoiding massive bleeding and lens damage are given.

Intravitreous حقن لأمراض العين تأسيس النموذجي

Intravitreous injection is a widely used technique in visual sciences research. It can be used to establish animal models with ocular diseases or as ...

Biology

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach

Subretinal injections have been successfully used in both humans and rodents to deliver therapeutic interventions of proteins, viral agents, and cells to the interphotoreceptor/subretinal compartment that has direct exposure to photoreceptors and the retinal pigment epithelium (RPE). Subretinal injections of plasminogen as well as recent preclinical and clinical trials have demonstrated safety and/or efficacy of delivering viral vectors and stem cells to individuals with advanced retinal disease. Mouse models of retinal disease, particularly hereditary retinal dystrophies, are essential for testing these therapies. The most common injection procedure in rodents is to use small transcorneal or transcleral incisions with an anterior approach to the retina. With this approach, the injection needle penetrates the neurosensory retina disrupting the underlying RPE and on insertion can easily nick the lens, causing lens opacification and impairment of noninvasive imaging. Accessing the subretinal space via a transcleral, posterior approach avoids these problems: the needle crosses the sclera approximately 0.5 mm from the optic nerve, without retinal penetration and avoids disrupting the vitreous. Collateral damage is limited to that associated with the focal sclerotomy and the effects of a transient, serous retinal detachment. The simplicity of the method minimizes ocular injury, ensures rapid retinal reattachment and recovery, and has a low failure rate. The minimal damage to the retina and RPE allows for clear assessment of the efficacy and direct effects of the therapeutic agents themselves. This manuscript describes a novel subretinal injection technique that can be used to target viral vectors, pharmacological agents, stem cells or induced pluripotent stem (iPS) cells to the subretinal space in mice with high efficacy, minimal damage, and fast recovery.

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach

Subretinal injections are the most common technique for delivering large therapeutic agents such as proteins and viral vectors to photoreceptors and the retinal pigment epithelium. An alternative method in mice that successfully targets the subretinal space with minimal collateral damage and fast recovery times is described here.

بديل والمصادق عليها طريقة حقن للوصول إلى الفضاء تحت الشبكية<i&gt; عبر</i&gt; نهج Transcleral الخلفي

Subretinal injections have been successfully used in both humans and rodents to deliver therapeutic interventions of proteins, viral agents, and cells to ...

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rNAION)

Nonarteritic anterior ischemic optic neuropathy (NAION) is a focal ischemic lesion of the optic nerve that affects 1/700 individuals throughout their lifetime. NAION results in optic nerve edema, selective loss of the retinal ganglion cell neurons (RGCs) and atrophy of the optic nerve. A rodent model of NAION that expresses most NAION features and sequelae has been developed, which is applicable to both rats and mice. This model utilizes a focal laser application of 532 nm wavelength to illuminate a photoactive dye, Rose Bengal (RB), to cause capillary damage and leakage at the targeted anterior optic nerve (the laminar region). After rNAION induction, there is an early optic nerve ischemia, optic nerve edema, and intraneural inflammation, followed by selective RGC and axonal loss. Since the optic nerve is a CNS white matter tract, the rNAION model is applicable to mechanistic studies of selective white matter ischemia, as well as neuroprotective analyses and short and long-term mechanisms of glial and neuronal response to ischemia.

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION

The following report describes how to replicate the rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION), using the appropriate dye, contact lens and laser parameters. We also reveal the appropriate steps for evaluating the rNAION lesion in vivo.

نموذج القوارض من Nonarteritic الإقفارية العصبي البصري الأمامي (rNAION)

Nonarteritic anterior ischemic optic neuropathy (NAION) is a focal ischemic lesion of the optic nerve that affects 1/700 individuals throughout their ...

Medicine

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

HR-SD-OCT is utilized to monitor the progression of photoreceptor degeneration in live mouse models, assess the delivery of therapeutic agents into the subretinal space, and to evaluate toxicity and efficacy in vivo. HR-SD-OCT uses near infrared light (800-880 nm) and has optics specifically designed for the unique optics of the mouse eye with sub-2-micron axial resolution. Transgenic mouse models of outer retinal (photoreceptor) degeneration and controls were imaged to assess the disease progression. Pulled glass microneedles were used to deliver sub retinal injections of adeno-associated virus (AAV) or nanoparticles (NP) via a trans-scleral and trans-choroidal approach. Careful positioning of the needle into the subretinal space was required prior to a calibrated pressure injection, which delivers fluid into the sub retinal space. Real time subretinal surgery was conducted on our retinal imaging system (RIS). HR-SD-OCT demonstrated progressive uniform retinal degeneration due to expression of a toxic mutant human mutant rhodopsin (P347S) (RHOP347S) transgene in mice. HR-SD-OCT allows rigorous quantification of all the retinal layers. Outer nuclear layer (ONL) thickness and photoreceptor outer segment length (OSL) measurements correlate with photoreceptor vitality, degeneration, or rescue. The RIS delivery system allows real-time visualization of subretinal injections in neonatal (~P10-14) or adult mice, and HR-SD-OCT immediately determines success of delivery and maps areal extent. HR-SD-OCT is a powerful tool that can evaluate the success of subretinal surgery in mice, in addition to measuring vitality of photoreceptors in vivo. HR-SD-OCT can also be used to identify uniform animal cohorts to evaluate the extent of retinal degeneration, toxicity, and therapeutic rescue in preclinical gene therapy research studies.

Here we demonstrate a novel approach to using high resolution spectral-domain optical coherence tomography (HR-SD-OCT) to assist delivery of gene therapy agents into the subretinal space, assess its areal coverage, and characterize photoreceptor vitality.

القرار أولتراهيغ الماوس الضوئية التماسك التصوير المقطعي لمساعدة الحقن داخل مقلة العين في أبحاث العلاج الجيني الشبكية

HR-SD-OCT is utilized to monitor the progression of photoreceptor degeneration in live mouse models, assess the delivery of therapeutic agents into the ...

Sheath-Preserving Optic Nerve Transection in Rats to Assess Axon Regeneration and Interventions Targeting the Retinal Ganglion Cell Axon

Retinal ganglion cell (RGC) axons converge at the optic nerve head to convey visual information from the retina to the brain. Pathologies such as glaucoma, trauma, and ischemic optic neuropathies injure RGC axons, disrupt transmission of visual stimuli, and cause vision loss. Animal models simulating RGC axon injury include optic nerve crush and transection paradigms. Each of these models has inherent advantages and disadvantages. An optic nerve crush is generally less severe than a transection and can be used to assay axon regeneration across the lesion site. However, differences in crush force and duration can affect tissue responses, resulting in variable reproducibility and lesion completeness. With optic nerve transection, there is a severe and reproducible injury that completely lesions all axons. However, transecting the optic nerve dramatically alters the blood brain barrier by violating the optic nerve sheath, exposing the optic nerve to the peripheral environment. Moreover, regeneration beyond a transection site cannot be assessed without reapposing the cut nerve ends. Furthermore, distinct degenerative changes and cellular pathways are activated by either a crush or transection injury.
The method described here incorporates the advantages of both optic nerve crush and transection models while mitigating the disadvantages. Hydrostatic pressure delivered into the optic nerve by microinjection completely transects the optic nerve while maintaining the integrity of the optic nerve sheath. The transected optic nerve ends are reapposed to allow for axon regeneration assays. A potential limitation of this method is the inability to visualize the complete transection, a potential source of variability. However, visual confirmation that the visible portion of the optic nerve has been transected is indicative of a complete optic nerve transection with 90-95% success. This method could be applied to assess axon regeneration promoting strategies in a transection model or investigate interventions that target the axonal compartments.

<meta charset="utf8"></head><body>قطع العصب البصري الحافظ على الغمد في الفئران لتقييم تجديد المحور العصبي والتدخلات التي تستهدف محور خلية العقدة الشبكية

This protocol describes an optic nerve transection that preserves the optic nerve sheath in rats. Hydrostatic pressure from microinjections into the optic nerve generate a complete transection, allowing for sutureless reapposition of the transected optic nerve ends and direct targeting of the axonal compartment in a transection model.

قطع العصب البصري الحافظ على الغمد في الفئران لتقييم تجديد المحور العصبي والتدخلات التي تستهدف محور خلية العقدة الشبكية

Retinal ganglion cell (RGC) axons converge at the optic nerve head to convey visual information from the retina to the brain. Pathologies such as ...

A Neonatal Rodent Model of Retroorbital Vein Injection

Intravenous (iv) injection is the most used route of drug administration in neonates in the clinical setting. Therefore, retroorbital vein injection is an important method for compound administration in research, where successful proof-of-concept studies can progress into much-needed neonatal clinical trials. Most intravenous studies in neonatal rodents use the superficial temporal/facial vein. However, retroorbital injection becomes unreliable in neonatal rodents older than 2 days after the skin darkens and the vein is no longer visible. In the present protocol, we describe the retroorbital injection of the venous sinus in both the neonatal mouse and rat at ages when the superficial temporal vein is no longer visible, but the eyes have not opened yet. Eye-opening facilitates retro-orbital injection by enabling the researcher to clearly see that they are not perforating the eye when inserting the needle. We demonstrate that this technique can be performed in a reliable and reproducible manner without adverse effects. Additionally, we show that it can be used in many studies, such as administering compounds to study neonatal brain injury.

This protocol aims to demonstrate a reproducible venous administration route that can be used in rats and mice throughout the neonatal period. This procedure is important for preclinical rodent studies that wish to mirror drug administration in neonatal care units primarily using intravenous administration.

نموذج القوارض الوليدية لحقن الوريد خلف الحجاج

Intravenous (iv) injection is the most used route of drug administration in neonates in the clinical setting. Therefore, retroorbital vein injection is an ...

Direct Vagus Nerve Injection Protocol For Rats

There is a relative abundance of strategies and methodologies to facilitate drug delivery to the central nervous system. However, drug delivery directly to the peripheral nervous system is less common, with fewer detailed methods publications available to aid researchers. Here, we describe a direct nerve injection method for peripheral nervous system drug delivery, using the vagus nerve as a model nerve. This method can be used in the treatment of autonomic nervous system disorders through targeting of the left vagus nerve, although this general injection method can be extrapolated to injection of other nerves with minor modification. This method explains all critical steps involved in the procedure involving microsurgery in anesthetized adult rats under a dissecting microscope. The use of a tracking dye is described to facilitate the monitoring of injection fidelity in real time. Illustrations of successful and failed injections are provided. If carried out properly, direct vagus nerve injections can be conducted in a safe manner that is well-tolerated by the rat without post-delivery complications. For example, once the surgeons were trained in this method, six out of six rats were successfully injected without any complications. This method of direct nerve injection for preclinical rat studies is capable of delivering agents (including but not limited to gene therapy) to peripheral nerves.

We present a protocol for direct vagus nerve injection in rats, enabling drug delivery directly into the nerve without post-injection complications. This method applies to preclinical neurological studies involving autonomic nervous system manipulation. It can be used for direct nerve injection for other nerves in rats and other species, with necessary modifications.

بروتوكول حقن العصب المبهم المباشر للفئران

There is a relative abundance of strategies and methodologies to facilitate drug delivery to the central nervous system. However, drug delivery directly ...

Transconjunctival Approach for Injection into the Rat Optic Nerve

The rat serves as an important model for studying disorders of the optic nerve, including heritable, traumatic, neoplastic, and autoimmune conditions. Accessing the rat optic nerve for experimental manipulations and injections is challenging due to the small size of the orbit and the vascularity of the surrounding orbital tissues. Previous techniques have involved a cutaneous incision, which carries a higher risk of infection and requires wound closure. This study aims to describe a unique, less invasive, and potentially more efficient approach to accessing the rat optic nerve. A transconjunctival incision, along with a rat spinal cord hook, is used to isolate the optic nerve for experimental injections. In these experiments, an adenoviral vector is injected into the optic nerve with the goal of using this technique for direct gene therapy delivery in the future. This technique can also be applied by investigators requiring access to the rat optic nerve for other experimental studies, including drug delivery and optic nerve injury research.

This protocol describes a unique technique using a transconjunctival approach to access the rat optic nerve for injections.

نهج عبر الملتحمة للحقن في العصب البصري للفئران

The rat serves as an important model for studying disorders of the optic nerve, including heritable, traumatic, neoplastic, and autoimmune conditions. ...

تقنيات الحد الأدنى الغازية لحقن الفئران في العصب البصري

Summary

Explore More Videos

أساليب التلاعب التجريبية بعد Transection العصب البصري الثدييات في الجهاز العصبي المركزي

Intravitreous حقن لأمراض العين تأسيس النموذجي

بديل والمصادق عليها طريقة حقن للوصول إلى الفضاء تحت الشبكية

نموذج القوارض من Nonarteritic الإقفارية العصبي البصري الأمامي (rNAION)

القرار أولتراهيغ الماوس الضوئية التماسك التصوير المقطعي لمساعدة الحقن داخل مقلة العين في أبحاث العلاج الجيني الشبكية

قطع العصب البصري الحافظ على الغمد في الفئران لتقييم تجديد المحور العصبي والتدخلات التي تستهدف محور خلية العقدة الشبكية

قطع العصب البصري الحافظ على الغمد في الفئران لتقييم تجديد المحور العصبي والتدخلات التي تستهدف محور خلية العقدة الشبكية

نموذج القوارض الوليدية لحقن الوريد خلف الحجاج

بروتوكول حقن العصب المبهم المباشر للفئران

نهج عبر الملتحمة للحقن في العصب البصري للفئران